| Julia Watson, OTD | |
|
1267 W Exchange Pkwy Ste 150, Allen, TX 75013-7111 | |
| (469) 342-0641 | |
| (972) 833-6079 |
| Full Name | Julia Watson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1267 W Exchange Pkwy Ste 150, Allen, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578274429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Ideal Physical Therapy Of Texas Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1538573746 PECOS PAC ID: 0547583809 Enrollment ID: O20141218000890 |
News Archive
A tiny genetic mutation is the key to understanding why nicotine-which binds to brain receptors with such addictive potency-is virtually powerless in muscle cells that are studded with the same type of receptor.
By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a tool that speeds up the analysis and publication of biomedical data from many months or years to mere minutes, transforming the way researchers communicate results of their studies.
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julia Watson, OTD 790 Remington Blvd, Bolingbrook, IL 60440-4909 Ph: (866) 370-8206 | Julia Watson, OTD 1267 W Exchange Pkwy Ste 150, Allen, TX 75013-7111 Ph: (469) 342-0641 |
News Archive
A tiny genetic mutation is the key to understanding why nicotine-which binds to brain receptors with such addictive potency-is virtually powerless in muscle cells that are studded with the same type of receptor.
By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a tool that speeds up the analysis and publication of biomedical data from many months or years to mere minutes, transforming the way researchers communicate results of their studies.
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
› Verified 6 days ago
Kelly Frye, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 915 W Exchange Pkwy Ste 100, Allen, TX 75013 Phone: 214-547-1571 | |
Laura Battaia, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 916 Carnegie Ct, Allen, TX 75002 Phone: 972-742-0442 | |
Katie Peacock, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 N Watters Rd Ste 150, Allen, TX 75013 Phone: 469-675-3153 Fax: 469-675-3154 | |
Mrs. Joella Dawn Mcgrew, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 W Main St, Suite 111, Allen, TX 75013 Phone: 214-509-6961 Fax: 214-382-0943 | |
Jennifer Lopez, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 Junction Dr, Allen, TX 75013 Phone: 469-675-3153 | |
Mckenzie Leigh Moninger, COTA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 Junction Dr, Allen, TX 75013 Phone: 469-675-3153 | |
Karen Kaye Murray, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1501 Bellevue Ct, Allen, TX 75013 Phone: 214-986-9909 |